Delivery Order SPE2DR25D1034-SPE2DR26FPW6F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,543.42 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,970.34 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on December 19, 2025, with completion scheduled for December 22, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal contract portfolio supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,928.27 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $6,425.86 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract reflects a routine pharmaceutical supply procurement from the company's existing indefinite delivery contract with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $4,086.86 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on December 17, 2025, with completion scheduled for December 18, 2025. This competitively awarded, firm fixed-price delivery order was performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $2,496.87 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18 units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 28, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $35,938.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,752.65 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under a larger procurement vehicle. No set-aside designation was used for this...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPW6FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,787.85 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on December 22, 2025, with completion scheduled for December 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen is a major pharmaceutical distributor providing a broad range of medications and medical supplies to federal customers, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal awards reflects its capability to meet competitive procurement requirements across multiple therapeutic domains and deliver both brand-name and generic pharmaceutical products at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/21/25 |